78.06
전일 마감가:
$77.69
열려 있는:
$77.06
하루 거래량:
3.16M
Relative Volume:
0.57
시가총액:
$32.73B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
12.93
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
-4.02%
1개월 성능:
-31.63%
6개월 성능:
-38.66%
1년 성능:
-53.71%
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ZTS
Zoetis Inc
|
78.08 | 32.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.24 | 50.43B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.55 | 41.13B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
8.885 | 40.12B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
UTHR
United Therapeutics Corp
|
546.38 | 23.64B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
ZTS Class Action ReminderRobbins LLP Reminds Investors - GlobeNewswire
Law Offices of Frank R. Cruz Encourages Zoetis Inc. (ZTS) Shareholders To Inquire About Securities Fraud Class Action - Business Wire
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
‘Milestone’ as VMD approves Zoetis’ Lenivia for OA - Vet Times
Zoetis Inc. (ZTS): Among The Most Oversold S&P 500 Stocks So Far in 2026 - Yahoo Finance
ZOETIS DEADLINE: Investors of Zoetis Inc. (NYSE: ZTS) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on July 27, 2026 - The Globe and Mail
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
GRABAR LAW OFFICE INVESTIGATES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZOETIS, INC. (ZTS) - marketscreener.com
ZTS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Zoetis Lawsuit Puts Companion Animal Disclosures And Valuation Gap In Focus - simplywall.st
Here’s Why Zoetis (ZTS) Is one of the Best Wide Moat Stocks to Buy According to Wall Street Analysts - Yahoo Finance
Kaplan Fox Encourages Investors of Zoetis Inc. (NYSE: ZTS) to Contact the Firm Before Lead Plaintiff Deadline on July 27, 2026 - NewMediaWire
ZTS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
ZTS - Finviz
Kaplan Fox Alerts Investors of Zoetis Inc. (NYSE: ZTS) to a Securities Class Action Deadline on July 27, 2026 - NewMediaWire
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Zoetis stock hits 52-week low at $111.25 amid market challenges - Investing.com Nigeria
ZTS Stock Price, Quote & Chart | ZOETIS INC (NYSE:ZTS) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Encourages Zoetis, Inc. (ZTS) - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Zoetis, Inc. (ZTS) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
ZOETIS INC. (ZTS) INVESTOR ALERT Investors With Large - GlobeNewswire
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit - PR Newswire
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Rosen Law Firm Urges Zoetis Inc. (NYSE: ZTS) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
Class action lawsuit filed against Zoetis over ... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
FinancialContentLaw Offices of Howard G. Smith Encourages Zoetis Inc. (ZTS) Shareholders To Inquire About Securities Fraud Class Action - FinancialContent
Class action filed against Zoetis over alleged misleading statements on product growth and market share. - Pluang
ZTS INVESTOR ALERT: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead the Zoetis Class Action Lawsuit - PR Newswire
Zoetis (ZTS) Still Has an Animal Health Franchise Worth Looking Through the Noise - AlphaStreet
ZTS Stockholder Alert: Shareholder Rights Law Firm Robbins LLP R - GuruFocus
Zoetis faces class action over alleged misleading claims on key animal health products. - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zoetis Inc.ZTS - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zoetis, Inc. (ZTS) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ZTS Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Zoetis Inc. - PR Newswire
Zoetis Stock Testing Price Floor – Buy Now? - Trefis
Argus Research downgrades Zoetis (ZTS) - MSN
Investor Notice: Robbins LLP Informs Investors of the Zoetis Inc. Class Action - The National Law Review
Behavioral Patterns of ZTS and Institutional Flows - Stock Traders Daily
Zoetis Investor Sues Over Dog Medicines’ Market Competitiveness - Bloomberg Law News
Labaton Keller Sucharow LLP Files Securities Class Action Against Zoetis, Inc. and Certain of Its Executives - Business Wire
Argus Research Downgrades Zoetis(ZTS.US) to Hold Rating - Moomoo
ZTS Downgraded by Argus Research -- Rating Changed to Hold - GuruFocus
Zoetis (ZTS) Securities Fraud InvestigationLevi & Korsinsky - Morningstar
Argus downgrades Zoetis stock rating on competition, margin pressure - Investing.com
Argus downgrades Zoetis stock rating on competition, margin pressure By Investing.com - Investing.com Canada
Argus Downgrades Zoetis to Hold From Buy - marketscreener.com
Assessing Zoetis (ZTS) Valuation After Steep Share Price Weakness And Profitability Concerns - simplywall.st
Zoetis, Inc. (ZTS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Zoetis, Inc. (ZTS) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Zoetis faces investor lawsuit after Q1 profit guidance cut and 21.5% stock drop. - Pluang
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):